FDA Import Refusal SCS-4419732-9/31/1 — STEDMAN PHARMACEUTICALS
The FDA refused shipment SCS-4419732-9/31/1 from STEDMAN PHARMACEUTICALS (India) on Jul 2, 2024. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Jul 2, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDC41 IBUPROFEN (ANTI-INFLAMMATORY)
- Charges
- 75